Sodium Chloride Injection, Solution
Product Images NDC 0338-9804

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sodium Chloride (NDC 0338-9804). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dhcp Letter 1.jpg (Image 01)

Dhcp Letter 1.jpg (Image 01)
The text provides important prescribing information regarding the temporary importation of 0.9% Sodium Chloride Injection from Shanghai, China by Baxter to address drug shortages. It states that the FDA has not approved these products manufactured by Baxter's Shanghai facility. Healthcare professionals will receive additional letters for other imported products and are advised to inspect the packaging for any defects before administration. The imported products have primary container labels written in Chinese, containing essential information in English such as the active pharmaceutical ingredient, concentration, volume, and product code. Please note that Baxter is the only entity authorized by the FDA to import or distribute these products in the United States during this temporary period.*
FDA Label Image

Dhcp Letter 2.jpg (Image 02)

Dhcp Letter 2.jpg (Image 02)
The text provides important information regarding imported medical products, including compatibility with Baxter sets, instructions for handling carton boxes, and the absence of barcodes on unit labels. It also highlights key differences between FDA-approved products and imported versions and provides contact information for reporting adverse events or product quality issues. For further details on prescribing information and ordering, individuals can refer to the provided contact information for Baxter.*
FDA Label Image

Dhcp Letter 3.jpg (Image 03)

Dhcp Letter 3.jpg (Image 03)
Lee Ann Schuette is the Vice President of Global and US Marketing for IV Solutions, Clinical Nutrition, and Pharmacy Tools at Baxter Healthcare Corporation. The text also mentions trademarks of Baxter International Inc. Such as Baxter and Viaflex.*
FDA Label Image

Dhcp Letter 4.jpg (Image 04)

Dhcp Letter 4.jpg (Image 04)
This text provides a product comparison table between an FDA-approved 0.9% Sodium Chloride Injection USP and an imported 0.9% Sodium Chloride Injection from Shanghai, China. The comparison includes differences in product name, label volume, language, indications, active ingredients, additional information, storage conditions, and container type. Key distinctions such as label volume options, indications for use, active ingredients, storage temperature, and container type are outlined for both products.*
FDA Label Image

Dhcp Letter 5.jpg (Image 05)

FDA Label Image

Dhcp Letter 6.jpg (Image 06)

Dhcp Letter 6.jpg (Image 06)
This text appears to be a label for a 0.9% Sodium Chloride Injection solution in a 1000ml container produced by Baxter. The label includes information on storage instructions, product description, manufacturer details, and lot numbers for quality control. Sodium chloride solutions are commonly used in medical settings for various purposes, such as replenishing electrolytes and treating certain medical conditions.*
FDA Label Image

Sodium Chloride A6c1322 Representative Container Label.jpg (Image 07)

FDA Label Image

Sodium Chloride A6c1323 Representative Container Label.jpg (Image 08)

FDA Label Image

Sodium Chloride A6c1324 Representative Container Label.jpg (Image 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.